Document Detail

Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.
MedLine Citation:
PMID:  21069319     Owner:  NLM     Status:  In-Data-Review    
PURPOSE: Postmortem studies indicate a loss of nicotinic acetylcholine receptor (nAChRs) in Alzheimer's disease (AD). In order to establish whether these changes in the cholinergic system occur at an early stage of AD, we carried out positron emission tomography (PET) with a specific radioligand for the α4β2* nicotinic acetylcholine receptor (α4β2* nAChR) in patients with mild to moderate AD and in patients with amnestic mild cognitive impairment (MCI), who have a high risk to progress to AD.
METHODS: Nine patients with moderate AD, eight patients with MCI and seven age-matched healthy controls underwent 2-[(18)F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[(18)F]FA-85380) PET. After coregistration with individual magnetic resonance imaging the binding potential (BP(ND)) of 2-[(18)F]FA-85380 was calculated using either the corpus callosum or the cerebellum as reference regions. PET data were analysed by region of interest analysis and by voxel-based analysis.
RESULTS: Both patients with AD and MCI showed a significant reduction in 2-[(18)F]FA-85380 BP(ND) in typical AD-affected brain regions. Thereby, the corpus callosum was identified as the most suitable reference region. The 2-[(18)F]FA-85380 BP(ND) correlated with the severity of cognitive impairment. Only MCI patients that converted to AD in the later course (n = 5) had a reduction in 2-[(18)F]FA-85380 BP(ND).
CONCLUSION: 2-[(18)F]FA-85380 PET appears to be a sensitive and feasible tool for the detection of a reduction in α4β2* nAChRs which seems to be an early event in AD. In addition, 2-[(18)F]FA-85380 PET might give prognostic information about a conversion from MCI to AD.
Kai Kendziorra; Henrike Wolf; Philipp Mael Meyer; Henryk Barthel; Swen Hesse; Georg Alexander Becker; Julia Luthardt; Andreas Schildan; Marianne Patt; Dietlind Sorger; Anita Seese; Herman-Josef Gertz; Osama Sabri
Related Documents :
17960479 - Alpha4beta2-nicotinic receptor binding with 5-ia in alzheimer's disease: methods of sca...
10870969 - Analysis of blood plasma proteins in patients with alzheimer's disease by two-dimension...
15084789 - Temporal lobe hypoperfusion in isolated amnesia with slow onset: a single photon emissi...
2136389 - Subgroups in dementia of the alzheimer type identified using positron emission tomography.
1811769 - Delirium: phenomenologic and etiologic subtypes.
1495679 - Single photon emission computed tomography using 99tcm-hmpao in alzheimer's disease.
25187589 - Primary epiphyseal osteomyelitis caused by mycobacterium species in otherwise healthy t...
15939719 - Is the new who classification of neuroendocrine tumours useful for selecting an appropr...
19427449 - Relation of aortic valve and coronary artery calcium in patients with chronic kidney di...
Publication Detail:
Type:  Journal Article     Date:  2010-11-11
Journal Detail:
Title:  European journal of nuclear medicine and molecular imaging     Volume:  38     ISSN:  1619-7089     ISO Abbreviation:  Eur. J. Nucl. Med. Mol. Imaging     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101140988     Medline TA:  Eur J Nucl Med Mol Imaging     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  515-25     Citation Subset:  IM    
Department of Nuclear Medicine, University of Leipzig, Liebigstr. 18, 04103, Leipzig, Germany,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenogr...
Next Document:  Usefulness and limitations of (99m)Tc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in t...